Publicaciones en las que colabora con FEDERICO GARRIDO TORRES-PUCHOL (41)

2022

  1. Study of HLA-A, -B, -C, -DRB1 and -DQB1 polymorphisms in COVID-19 patients

    Journal of Microbiology, Immunology and Infection, Vol. 55, Núm. 3, pp. 421-427

2011

  1. Frequent loss of heterozygosity in the β2-microglobulin region of chromosome 15 in primary human tumors

    Immunogenetics, Vol. 63, Núm. 2, pp. 65-71

2007

  1. Analysis of HLA class I alterations in tumors: Choosing a strategy based on known patterns of underlying molecular mechanisms

    Tissue Antigens

  2. Analysis of KIR gene frequencies in HLA class I characterised bladder, colorectal and laryngeal tumours

    Tissue Antigens, Vol. 69, Núm. 3, pp. 220-226

  3. MHC Class I Antigens and Immune Surveillance in Transformed Cells

    International Review of Cytology, Vol. 256, pp. 139-189

  4. Total loss of HLA class I expression on a melanoma cell line after growth in nude mice in absence of autologous antitumor immune response

    International Journal of Cancer, Vol. 121, Núm. 9, pp. 2023-2030

2006

  1. LOH at 6p21.3 region and HLA class altered phenotypes in bladder carcinomas

    Immunogenetics, Vol. 58, Núm. 7, pp. 503-510

2005

  1. High frequency of homozygosity of the HLA region in melanoma cell lines reveals a pattern compatible with extensive loss of heterozygosity

    Cancer Immunology, Immunotherapy, Vol. 54, Núm. 2, pp. 141-148

  2. Involvement of the chaperone tapasin in HLA-B44 allelic losses in colorectal tumors

    International Journal of Cancer, Vol. 113, Núm. 4, pp. 611-618

  3. TAP1 and TAP2 polymorphisms and their linkage disequilibrium with HLA-DR, -DP, and -DQ in an Eastern Andalusian population

    Human Immunology, Vol. 66, Núm. 8, pp. 921-930

2004

  1. Distribution of HLA class I altered phenotypes in colorectal carcinomas: High frequency of HLA haplotype loss associated with loss of heterozygosity in chromosome region 6p21

    Immunogenetics, Vol. 56, Núm. 4, pp. 244-253

2003

  1. Analysis of HLA expression in human tumor tissues

    Cancer Immunology, Immunotherapy, Vol. 52, Núm. 1, pp. 1-9

  2. High frequency of HLA-B44 allelic losses in human solid tumors

    Human Immunology, Vol. 64, Núm. 10, pp. 941-950

2002

  1. Impaired surface antigen presentation in tumors: Implications for T cell-based immunotherapy

    Seminars in Cancer Biology, Vol. 12, Núm. 1, pp. 15-24

  2. Multiple mechanisms generate HLA class I altered phenotypes in laryngeal carcinomas: High frequency of HLA haplotype loss associated with loss of heterozygosity in chromosome region 6p21

    Cancer Immunology, Immunotherapy, Vol. 51, Núm. 7, pp. 389-396

2001

  1. A nucleotide insertion in exon 4 is responsible for the absence of expression of an HLA-a*0301 allele in a prostate carcinoma cell line

    Immunogenetics, Vol. 53, Núm. 7, pp. 606-610

  2. HLA class II allele distribution in the Gypsy community of Andalusia, southern Spain

    Tissue Antigens, Vol. 57, Núm. 2, pp. 138-143

  3. Loss of HLA-B44 and type II altered HLA phenotype in human tumors

    European Journal of Immunogenetics, Vol. 28, Núm. 2, pp. 327

2000

  1. Criteria to define HLA haplotype loss in human solid tumors

    Tissue Antigens

  2. Molecular strategies to define HLA haplotype loss in microdissected tumor cells

    Human Immunology, Vol. 61, Núm. 10, pp. 1001-1012